More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line
Genomic sequencing of CD19 in the Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line.
Genomic sequencing of CD19 in the Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line.
Genomic sequencing of CD19 in the Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line.

Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line

Research Use Only
82625
BPS Bioscience
Category(Cell) Culture
Product group (Cell) Culture
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    BPS Bioscience
  • Product Name
    Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line
  • Delivery Days Customer
    7
  • Certification
    Research Use Only
  • Scientific Description
    Firefly Luciferase CD19/CD20 Double Knockout Raji Cell Line is a Raji cell line in which CD19 (Cluster of Differentiation 19, B lymphocyte surface antigen B4, or CVID3) and CD20 (B-lymphocyte antigen CD20, or MS4A1) have been genetically removed from Raji cells using CRISPR/Cas9 genome editing, while also constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter. This cell line was generated by using Firefly Luciferase Lentivirus (BPS Bioscience #79692) on CD19/CD20 Double Knockout Raji Cell Line (BPS Bioscience #82623). This cell line has been validated by genome sequencing, flow cytometry and luciferase activity measurement.
  • Storage Instruction
    Liquid Nitrogen
  • UNSPSC
    12352207